Dairaghi Daniel
- The CCR4 antagonist CCX6239 for the treatment of allergic airways diseaseBy Zhenhua Miao, Yu Wang, Leleti Manmohan, Yu Wang, Jarek Kalisiak, Jay Powers, Matthew Walters, Dairaghi Daniel, Lisa Seitz, Tim Sullivan and Tom SchallZhenhua Miao1Drug Discovery, ChemoCentryx, Mountain View, CA, United StatesYu Wang1Drug Discovery, ChemoCentryx, Mountain View, CA, United StatesLeleti Manmohan1Drug Discovery, ChemoCentryx, Mountain View, CA, United StatesYu Wang1Drug Discovery, ChemoCentryx, Mountain View, CA, United StatesJarek Kalisiak1Drug Discovery, ChemoCentryx, Mountain View, CA, United StatesJay Powers1Drug Discovery, ChemoCentryx, Mountain View, CA, United StatesMatthew Walters1Drug Discovery, ChemoCentryx, Mountain View, CA, United StatesDairaghi Daniel1Drug Discovery, ChemoCentryx, Mountain View, CA, United StatesLisa Seitz1Drug Discovery, ChemoCentryx, Mountain View, CA, United StatesTim Sullivan1Drug Discovery, ChemoCentryx, Mountain View, CA, United StatesTom Schall1Drug Discovery, ChemoCentryx, Mountain View, CA, United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.